FIELD: biotechnologies.
SUBSTANCE: pharmaceutical composition includes bacteriophages obtained by cultivation on nutritional medium containing glucose, sodium chloride, twice-substituted sodium phosphate, liquid autolysed yeast and clean water in the specified ratio, and dried and having a filler without lyophilisation, in the form of pills with a gastral-resistant coating.
EFFECT: invention allows increasing safety of pharmaceutical composition.
7 ex
Title | Year | Author | Number |
---|---|---|---|
SEXTAPHAGE (PYOBACTERIOPHAGE POLYVALENT) OR BACTERIOPHAGE SALMONELLOUS PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2410084C1 |
BACTERIOPHAGE-CONTAINING PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2002 |
|
RU2241446C2 |
ANTIBACTERIAL PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING BACTERIOPHAGES | 2016 |
|
RU2660355C2 |
METHOD FOR PREPARING POLYBACTERIOPHAGE | 2002 |
|
RU2247151C2 |
IMMUNOBIOLOGICAL BACTERICIDAL PREPARATION (VERSIONS) | 2007 |
|
RU2366708C2 |
BACTERIOPHAGE COMPOSITION (VERSIONS) | 2007 |
|
RU2366437C2 |
PREPARATION FOR TREATMENT OF PATIENT WITH SUPPURATIVE-INFLAMMATORY DISEASES (VARIANTS) | 1997 |
|
RU2144368C1 |
BIOPHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL AND PROBIOTIC ACTIVITY AND DOSAGE FORM BASED ON IT | 2021 |
|
RU2795770C2 |
ANTIBACTERIAL COMPOSITION FOR PREVENTION OR TREATMENT OF HOSPITAL INFECTIONS (VERSIONS), BACTERIOPHAGE STAMPS USED TO OBTAIN SUCH COMPOSITION | 2015 |
|
RU2628312C2 |
0 |
|
SU1781297A1 |
Authors
Dates
2014-06-20—Published
2012-10-02—Filed